AHA, AARP CEOs Highlight ‘Exorbitantly-priced Drugs’ in Hill OpEd
AHA President and CEO Rick Pollack and AARP CEO Jo Ann Jenkins today authored an OpEd in The Hill discussing the skyrocketing costs of prescription drugs and what they mean for patients and our health care system. “Ultimately, the current system of exorbitantly-priced drugs is unsustainable for everyone — patients, employers, insurers, and taxpayer-funded programs like Medicare and Medicaid,” they wrote. “We stand ready to work together to find commonsense and innovative solutions that will help make drugs affordable for everyone.” Read more.
Related News Articles
Blog
As we celebrate Hispanic Heritage Month, it's an opportune moment for us in the Hispanic community to assess our progress in health care, celebrate our…
Headline
AHA’s Behavioral Health Team, in collaboration with AHA’s Institute for Diversity and Health Equity, Sept. 16 released an infographic highlighting minority…
Headline
The AHA Sept. 9 released a report highlighting how hospitals’ arrangements with community and specialty pharmacies improve access to care for underserved…
Headline
A district court in Baltimore Sept. 5 ruled against drug companies and PhRMA, denying their attempt to obtain a preliminary injunction against 340B pricing for…
Headline
The AHA, 340B Health and the American Society of Health-System Pharmacists last week filed an amicus brief in a federal district court in Missouri, defending…
Headline
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the…